Mirae Asset Global Investments’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,004
Closed -$495K 2616
2024
Q1
$495K Hold
15,004
﹤0.01% 1905
2023
Q4
$323K Hold
15,004
﹤0.01% 2167
2023
Q3
$288K Hold
15,004
﹤0.01% 2146
2023
Q2
$381K Hold
15,004
﹤0.01% 2072
2023
Q1
$542K Hold
15,004
﹤0.01% 1878
2022
Q4
$594K Buy
15,004
+272
+2% +$11.3K ﹤0.01% 1796
2022
Q3
$687K Buy
14,732
+4,420
+43% +$205K ﹤0.01% 1696
2022
Q2
$452K Buy
+10,312
New +$567K ﹤0.01% 1802
2017
Q4
Sell
-28,500
Closed -$2.59M 719
2017
Q3
$2.59M Buy
28,500
+8,399
+42% +$719K 0.05% 289
2017
Q2
$1.5M Buy
+20,101
New +$1.61M 0.03% 358

Other funds holding NVRO

Mirae Asset Global Investments's NVRO Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of NEVRO CORP. (NVRO) in Q2 2024, closing a stake of 15,004 shares — an estimated $495K sold.

Mirae Asset Global Investments first reported a position in NVRO in Q2 2017 and held it in 10 quarters. The position peaked at $2.59M in Q3 2017. 152 funds tracked by Wall St. Rank hold NVRO as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining NEVRO CORP. position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 15,004 NEVRO CORP. shares in Q2 2024, an estimated $495K.
  • Mirae Asset Global Investments first reported a position in NEVRO CORP. in Q2 2017 and held it in 10 quarters.
  • Mirae Asset Global Investments's NEVRO CORP. position peaked at $2.59M in Q3 2017.
  • 152 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.